{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-086658","form_type":"8-K","ticker":"CALC","cik":"0001534133","company_name":"CalciMedica, Inc.","filed_at":"2026-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.359342+00:00","generated_at":"2026-05-15T22:14:36.259475+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CalciMedica reports 2025 net loss $29.6M; cash $13M; KOURAGE safety review finds no drug toxicity","bullets":["Net loss $29.6M ($1.97/share) vs $13.7M ($1.22/share) in 2024; R&D expense $15.2M, G&A $7.9M.","Cash, equivalents & short-term investments $13.0M as of Dec 31, 2025; expected to fund operations into Q4 2026.","KOURAGE trial in AKI discontinued; internal & external safety review found no evidence of drug-related toxicity.","Pivotal program design for Auxora in acute pancreatitis expected 1H 2026 following constructive FDA engagement.","CM5480 for PAH: IND submission anticipated in 2027; preclinical data published in JCI Insight."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-086658","json":"https://secwatch.observer/filing/0001193125-26-086658.json","markdown":"https://secwatch.observer/filing/0001193125-26-086658.md","text":"https://secwatch.observer/filing/0001193125-26-086658.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534133/000119312526086658/0001193125-26-086658-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534133/000119312526086658/ck0001534133-20260302.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:14:36.259475+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}